TRENDING LISTS: Dividend Aristocrats, Dow 30, Largest Market Cap Stocks & Warren Buffett's Portfolio

Another Biotech Winner? Please And Thank You.

This is a Post from the Symbol Surfing Blog from Fri, Aug 17, 2018.

I have been able to make a couple good trades in biotech stocks this year with BIIB and BMY.

Another one that looks good right now is Abbvie.

Abbvie originated as a spin-off of Abbott Laboratories.

This is a $150 billion market cap biotech stock that pays almost 4% in annual dividend yield.

Also, their P/E Ratio is in the low 20s.


"We’re still committed to be able to return significant capital to shareholders," the company’s CEO, Richard Gonzalez, said during the second-quarter earnings call in late July, adding that "we have the ability to continue to grow the dividend."

On the 1-year stock chart, I have highlighted the trading range between $90 and $100.

It would be great if the stock continues the post-earnings rally.

I wish I bought a couple days ago, but now I have seen more of a stronger confirmation on the stock price movement.

Obviously, I am hoping the stock price breaks through the resistance at $100 and heads back to previous highs.

On the downside, it looks like there is a lot of support at $90.

In that case, I would be ok waiting while receiving the dividend.

Either way, I like this trade.


What do you think about "Another Biotech Winner? Please And Thank You."?

Let me know in the comments section!

If you think your friends would like this, please share it. Thanks!

Fri, Aug 17, 2018 ABBV @ $98.81